Regulatory News:
Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263) (Paris:MKEA), the leader in the endomicroscopy market, today announces its schedule for the publication information for 2012.
Event | Date * | |
2011 annual revenues | Thursday January 19, 2012 | |
2011 annual results | Wednesday April 4, 2012 | |
2012 First-quarter revenues | Tuesday May 15, 2012 | |
Annual General Meeting | Friday June 15, 2012 | |
2012 First-half revenues | Monday July 30, 2012 | |
2012 first-half results | Thursday August 30, 2012 | |
2012 third-quarter revenues | Tuesday November 13, 2012 |
* Subject to modification. Press releases are published after market closes.
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company and a leader in endomicroscopic innovation. The company designs, develops and markets innovative tools to visualize and help detect abnormalities in the gastrointestinal and pulmonary tracts. Its flagship product (Cellvizio®, a probe-based confocal laser endomicroscopy (pCLE) system) provides physicians and researchers with high-resolution cellular views of tissue inside the body. Large, international, multicenter clinical trials have demonstrated Cellvizio®'s ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce hospital costs, Cellvizio can be used with almost any endoscope. Cellvizio® has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the gastrointestinal and pulmonary tracts.
For more information on Mauna Kea Technologies, visit www.maunakeatech.com
Next press release: 2011 annual revenues - Thursday January 19, 2012
United States
Erich Sandoval
Lazar
Partners Ltd.
Tel: +1 917 497 2867
esandoval@lazarpartners.com
or
Mauna
Kea Technologies
Alexander Bryson
Marketing
Communications and Brand Manager
Tel: +33 (0) 1 70 08 09 92
alexander@maunakeatech.com
or
France
and Europe
ALIZE RP
Caroline Carmagnol
Tel:
+ 33 1 42 68 86 43 / + 33 6 64 18 99 59
caroline@alizerp.com
Anne?Sophie
Cosquéric
Tel: + 33 1 42 68 86 41
Anne-sophie@alizerp.com
or
NewCap
Investor
Relations and Financial Communication
Pierre Laurent / Florent Alba
Tel:
+33 1 44 71 94 94
maunakea@newcap.fr